Search results for: d842V

Home/Search: d842V
7 08, 2019

Blueprint Medicines Announces Next Step for Avaprinitib

By |2019-08-07T13:24:21-04:00August 7th, 2019|Drug Treatment, News|

Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST Blueprint Medicines announced today that the FDA and the EMA have [...]

17 12, 2018

An Exciting Time for GIST Research

By |2019-01-02T14:49:47-05:00December 17th, 2018|Conferences, Newsletter, Research|

Left to right: Laura Occhiuzzi, Pete Knox, Alyssa O’Driscoll, Sarcoma Alliance, Annie Achee, National LeioMyoSarcoma Foundation, Denise Reinke, SARC, and Mitch Achee, National LeioMyoSarcoma Foundation. GIST Research from CTOS 2018 A web-based [...]

29 06, 2018

New Technology Developed Which Can Predict GIST Patient’s Response to Drugs with Amazing Accuracy

By |2019-07-03T10:48:28-04:00June 29th, 2018|GIST Education, Mutational Testing, News, Newsletter|

Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]

18 06, 2018

GIST Updates from the ASCO Annual Meeting 2018

By |2020-05-19T10:25:20-04:00June 18th, 2018|Clinical Trials, News, Research|

Executive Director, Norman Scherzer, and Real World Evidence Data Scientist, Dr. Yu Wang, of the Life Raft Group recently attended the ASCO (American Society of Clinical Oncologists) 2018 meeting in Chicago. Dr. Wang describes [...]

Need a new search?

If you didn't find what you were looking for, try a new search!